Clinical trials
Completed Phase 2 Macular Degeneration trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
99 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 11 |
| 2007 | 6 |
| 2008 | 10 |
| 2009 | 5 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 10 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 99 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allergan | 7 |
| Alcon Research | 5 |
| National Eye Institute (NEI) | 5 |
| GlaxoSmithKline | 4 |
| Manhattan Eye, Ear & Throat Hospital | 3 |
| Novartis Pharmaceuticals | 3 |
| Regeneron Pharmaceuticals | 3 |
| Janssen Research & Development, LLC | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| Santen Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 99 |
| Choroidal Neovascularization | 17 |
| Geographic Atrophy | 11 |
| Diabetic Retinopathy | 5 |
| Macular Edema | 5 |
| Wet Macular Degeneration | 5 |
| Eye Diseases | 4 |
| Retinal Diseases | 4 |
| Neovascularization, Pathologic | 3 |
| Retinal Degeneration | 3 |
Trials
Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.